BMRN

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 24.3% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) now have 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between..

November 28, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 25.9% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) now have 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between..

November 22, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 30.3% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) have now 23 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between..

November 16, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 36.8% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) have now 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price..

November 9, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 44.4% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) now have 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’...

October 31, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 32.7% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) now have 22 market analysts covering the stock. The analyst consensus now points to a rating..

October 12, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 32.3% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) now have 22 analysts in total covering the stock. The consensus rating is pointing to ‘buy’...

September 20, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 28.5% Upside Potential

BioMarin Pharmaceutical Inc. which can be found using ticker (BMRN) have now 23 market analysts covering the stock. The analyst consensus now points to a rating..

September 7, 2023

BioMarin Pharmaceutical Inc. – Consensus ‘buy’ rating and 24.4% Upside Potential

BioMarin Pharmaceutical Inc. with ticker code (BMRN) now have 23 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between..